GLP-1 drugs are reshaping our bodies, but also our society. They may even help to treat major diseases once thought incurable ...

President Donald Trump’s comments about autism this week sparked widespread concern and criticism from many in the community.

The agency expanded use of an old drug as a treatment for some people with autism. The endorsement sent some customers ...

Chinese biotech firm is among dozens of mainland drug makers seeking to compete in the global market for diabetes and ...

The FDA announced Monday that it would change the drug’s label to reflect potential benefits in reducing autism symptoms.

Trump Administration introduced what it says is an “exciting treatment” for autism: leucovorin, a decades-old medicine that ...

GLP-1 receptor agonists and SGLT2 inhibitors are linked to greater reduction in risk for Alzheimer’s disease than DPP-4 ...

Animal studies say rapamycin can slow aging – but does it work in humans? A new review finds the evidence for the off-label, ...

A controversial anti-parasitic drug said without evidence to be a treatment for COVID-19 could be available over the counter.

According to Martin Makary, head of the US Food and Drug Administration (FDA), the drug leucovorin will help “hundreds of ...

Recently, a different weight loss drug, ecnoglutide, with an active ingredient of the peptide ecnoglutide, has been utilized ...